Author: Aindrila Mitra
-

Chapter II (Demand) Strategy: When It’s Worth It
There’s a moment in every startup journey when demand starts to whisper. Not scream. Not explode. Just whisper. You see it in small signs—users sticking around, investors asking sharper questions, competitors suddenly paying attention. That’s when founders face one of the trickiest choices in business: how hard should you lean into demand? Seeing the Signs:…
-

PCT Search Report & Written Opinion: What to Do Next
When you receive your PCT search report and written opinion, it can feel overwhelming, but this moment is where smart founders separate themselves from the rest. The report isn’t a rejection—it’s a preview, a chance to see how your invention compares to existing technology before spending big money filing in different countries. Understanding What Your…
-

Choosing the Right ISA/IPEA: Cost, Speed, and Quality
When you file a PCT (Patent Cooperation Treaty) application, you’ll face one big decision that can quietly shape everything that follows — which International Searching Authority (ISA) or International Preliminary Examining Authority (IPEA) you choose. What Your ISA and IPEA Actually Do — And Why They Matter More Than You Think When you file a…
-

PCT Timeline Made Simple: 12, 16, 22, 30/31 Months
If you’re building something new—an AI model, a new kind of chip, or some deep tech no one’s seen before—you already know how fast the world moves. You’re racing to build, raise funds, and find users. But when it comes to protecting your idea globally, the rules suddenly get messy. That’s where the PCT timeline…
-

PCT Basics: How the International Patent Route Works
If you’ve ever built something new and realized it could change the world, your next thought might be, “How do I protect this globally?” That’s where the PCT—short for Patent Cooperation Treaty—steps in. It’s not a new kind of patent, and it’s not a shortcut to automatic worldwide protection. But it’s the smartest way to…
-

Playbook: Year-by-Year Plan to Maximize PTA/PTE Across a Portfolio
Every day that a patent stays alive can mean millions in revenue or market advantage. Yet most founders and R&D teams lose months—or even years—of patent life without realizing it. They don’t lose it because their inventions are weak. They lose it because they never had a game plan for maximizing Patent Term Adjustment (PTA)…
-

M&A and Licensing: Valuing Extra Patent Term
When startups get bought, merged, or licensed, everyone looks at the same few things: revenue, customers, and IP. Patents are often the crown jewels of these deals. But here’s the thing most founders and even many investors miss — not all patents are created equal. What “Extra Patent Term” Really Means — And Why It’s…
-
Analytics Dashboards for PTA/PTE: KPIs That Matter
In the world of drug development, time is everything. Every day a new therapy waits for approval, millions of dollars hang in the balance. That’s why analytics dashboards for PTA (Patent Term Adjustment) and PTE (Patent Term Extension) are quietly becoming the heartbeat of smarter IP management in life sciences. They turn what used to…
-
Quality Control Checklist: PTA/PTE Errors to Catch Before Filing
If you’ve ever filed a patent, you already know the smallest mistake can cost you time, money, or worse — your rights. When it comes to Patent Term Adjustment (PTA) and Patent Term Extension (PTE), precision isn’t optional. It’s the difference between getting the full protection your invention deserves or losing months—sometimes years—of exclusivity because…
-
Portfolio Strategy: Which Assets Deserve PTA/PTE Spend
Building a patent portfolio isn’t just about filing every idea that pops up. It’s about spending smart. When you’re running a startup or leading a tech team, every dollar and every week counts. You can’t protect everything — and you shouldn’t try to. The smartest founders know how to spot the few assets that deserve…